ATLAS fair value
ATLAS has no fair value for this stock today.
HBM Healthcare Investments stock price today, ATLAS forecast and fair value
Financial Services · Asset Management · SIX Swiss Exchange · Switzerland
Prices as of Oct 27, 2026 · CHF
ATLAS has no fair value for this stock today.
54%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives HBM Healthcare Investments a 54% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 215.87 and CHF 230.30; in 9 out of 10, between CHF 203.84 and CHF 243.90. Estimated annual volatility is 16%.
ATLAS does not publish a fair value for HBMN.SW right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks HBMN.SW has traded between CHF 193.00 and CHF 258.00. Today it is 14.0% below that high and 15% above its low.
On the business: net margin is 98.9%; it trades at 2.3 times earnings.
Its beta is 0.74: it tends to move less than the market.
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies.
Want to see everything about HBM Healthcare Investments?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies.
54%: close to a coin flip. In half of the simulated outcomes, HBMN.SW ends the month between CHF 215.87 and CHF 230.30.
HBM Healthcare Investments's market capitalization is CHF 1.5B. Its price-to-earnings (P/E) ratio is 2.3: you pay CHF 2.32 for each CHF 1.00 of yearly earnings.
Yes. HBMN.SW's current dividend yield is 3.96% at today's price (CHF 222.00).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy